Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

Ichnos Glenmark Innovation subsidiary IGI Therapeutics has signed an exclusive licensing agreement with AbbVie for ISB 2001, ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

On the skin, millions of microbial colonists quietly coexist with their host as microscopic allies that help maintain health ...

My age is 73, and I’ve had a steadily increasing PSA level for many years. In 2020, the result was 11.8 ng/mL, and it has ...

It's not a badge that I necessarily would say I am proud to have,” the actor, 52, tells PEOPLE of being a three-time cancer ...

The firm is launching a Phase II trial of its dendritic cell vaccine following promising preliminary efficacy and favorable safety results in Phase I.

While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.

Study: Targeting peptide antigens using a multiallelic MHC I-binding system. Image Credit: Nemes Laszlo / Shutterstock.com In a recent study published in Nature Biotechnology, researchers describe ...

RSV tests include nasal swabs or blood tests to detect the virus's genetic material or antibodies, but rapid tests provide quick results.

What is a hepatitis B surface antigen and why do doctors test for it? Read on to learn more about this blood test, including why doctors test for it and how to interpret test results.